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Objectives: cross-clamping of the infrarenal aorta is associated with complex haemodynamic disturbances. Several
experimental models of aortic cross-clamping (AXC) have been described with heterogeneous results. The main purpose
of this study was to establish an animal model in which infrarenal AXC could reproduce similar systemic and renal
haemodynamic changes to those observed in humans.
Methods: eleven anaesthetised pigs underwent AXC just below the renal arteries. Renal blood flow was measured using
clearance of 131I hippuran. Systemic and renal parameters were collected at 3 consecutive 30-min periods.
Results: AXC did not alter the extraction fraction of 131I hippuran but was accompanied by significant (13%) decrease
in cardiac index (p 0.005) and a 23% increase in mean arterial pressure (p 0.005). AXC induced significant 135%
increase in renal vascular resistance (p 0.012) and a 35% decrease in renal blood flow (p 0.016). This worsened after
removal of the aortic clamp, whereas systemic variables returned to baseline levels.
Conclusions: this AXC animal model reproduces the changes observed in humans. It provides a reliable animal model
which allows to investigate the underlying mechanisms of renal vasoconstriction and the effect of new drugs.
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Introduction
Infrarenal aortic reconstruction to treat aneurysmal,
occlusive and traumatic diseases is a commonly per-
formed and well-standardised surgical procedure.
However, renal impairment is a frequent postopera-
tive complication,1±4 possibly because infrarenal aortic
cross-clamping (AXC) is associated with complex
renal haemodynamic disturbances.5±7 Several experi-
mental models of infrarenal AXC have been described
with heterogeneous results.8±22 The main purpose of
this study was to establish an animal model in which
the infrarenal AXC could reproduce similar systemic
and renal haemodynamic changes to those observed
in humans.
Materials and Methods
Animal preparation
Experiments were performed on eleven female farm-
bred pigs with a mean weight of 18.5 3.1 kg
(15±22 kg). This study complied with the `` Guide for
the Care and Use of Laboratory Animals'' (NIH Pub-
lication No. 80-23, revised 1985) and was approved by
the animal experiment ethics committee of our insti-
tution. Pigs were fasted except for ad lib water for
twelve hours before anaesthetic induction. The ani-
mals were premedicated with intramuscular ketamine
(20 mg/kg), midazolam (0.5 mg/kg), and atropine
(2 mg). An intravenous catheter was placed in an ear
vein and lactated Ringer's solution was infused at a
rate of 1 ml kgÿ1 hÿ1 using an intravenous infusion
pump. Anaesthesia was induced with thiopentone
2±3 mg/kg. The animal's trachea was intubated and
mechanically ventilated (Monnal A) with isoflurane
(1%) in oxygen (100%), keeping end tidal isoflurane
concentration at 0.8±1 MAC and end tidal CO2 pres-
sure between 25 and 35 mmHg (Capnomag, Datex
Laboratory, Ultima, Finland). Sufentanyl was infused
continuously at the rate of 1.5 to 2 mg/kg/h after a
bolus injection of 10 mg just before abdominal incision.
Neuromuscular block was provided with pancuro-
nium bromide as needed.
After a short right-side neck incision, the external
carotid artery was cannulated and the catheter was
advanced into the common carotid artery for measure-
ment of mean arterial pressure (MAP) and for blood
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sampling at different time points. A thermodilution
pulmonary artery catheter was placed via a jugular
vein to measure central venous pressure (CVP), pul-
monary capillary wedge pressure (PCWP) and core
temperature.
A midline laparotomy was performed with the ani-
mal in a supine position. An open cystostomy through
a small vesical incision was used for indwelling cath-
eter insertion and complete urine collection. The infra-
renal part of the abdominal aorta was exposed as well
as the left renal veins. A catheter was inserted and
advanced into one of the left renal veins toward the
kidney for blood sampling at different time points. To
achieve AXC, a clamp was placed just below the renal
arteries and the incision was then closed around the
aortic clamp in order to avoid hypothermia as well as
traction on the mesentery and potential bowel ischae-
mia. Sodium heparin (100 IU/kg) was administered
intravenously before AXC. Temperature was main-
tained using a heating blanket. After completion of
the experiment, the animal was sacrificed.
Experimental protocol
Cardiac output (CO) was determined by thermodilu-
tion technique, using 5 ml iced 0.9% NaCl injected into
a separate central venous injection catheter, as the
average of three consecutive measurements not vary-
ing more than 10%. Cardiac index (CI), indexed stroke
volume (iSV) and indexed systemic vascular resist-
ance (iSVR) were calculated using the following
formulas:
CI (ml/min/kg)CO/weight
iSV (ml)CO/HR (heart rate)
iSVR (IU/kg)MAP/CI
Renal blood flow was measured using clearance of 131I
hippuran (CHIP). The labeled compound was injected
immediately after induction of anaesthesia as a bolus
of 10 mCi 131I hippuran, as recommended by the
Nuclear Medicine Laboratory of our institution. In
addition a continuous infusion of 20 mCi 131I hippuran
in 150 ml mannitol 20% at a rate of 25 ml/h was
administered throughout the study in order to obtain
an adequate urinary output (UO) and a stable blood
level of the labelled compound.
In order to calculate the extraction fraction of 131I
hippuran (EHIP), arterial blood was sampled from the
carotid artery and renal venous blood was withdrawn
very slowly to avoid vena cava contamination. Urine
was sampled twice each period and only the second
sample was used to avoid any washout effect. Plasma
and urinary radioactivity of 131I hippuran were mea-
sured with an auto-gamma scintillation spectrometer.
CHIP, EHIP, renal blood flow (RBF) and renal vascular
resistance (RVR) were calculated using the following
equations:6
CHIP (ml/min)urinary 131I hippuranUO (ml/
min)/plasma 131I hippuran
EHIP arterial plasma 131I hippuran±renal venous
plasma 131I hippuran/arterial plasma 131I hippuran
RBF (ml/min) (CHIP/EHIP) (100/100 haematocrit)
RVR (UI)MAP/RBF
The renal fraction of CO is expressed as RBF/CO
ratio.
After surgical preparation, pigs were allowed to sta-
bilise for 30 min. At the end of the stabilisation period,
baseline measurements of HR, MAP, PCWP, CI, iSV
and iSVR were performed (baseline). Systemic and
renal parameters were collected at 3 consecutive per-
iods of 30 min each: (a) immediately before infrarenal
AXC, (b) at the end of the 30-min AXC period and
(c) 30 min following the discontinuation of AXC.
Statistical analyses
Results are expressed as median and interquartile
range, median (25; 75%), because some data were not
normally distributed. Overall effects were evaluated
by the Friedman test within the group. In the case of
significant differences, further comparisons were
made with the Wilcoxon test. A value of p5 0.05 was
considered significant, but the Bonferroni±Dunn pro-
cedure was used for correction of multiple
comparisons when appropriate.
Results
Experiments were completed in all eleven pigs. The
plasma radioactivity of 131I hippuran was stable dur-
ing the three periods as shown in Table 1. The aortic
cross-clamping did not alter the extraction fraction of
131I hippuran and the variation of extraction related to
AXC was non-significant (Table 1 and Fig. 1).
Effects of AXC on systemic haemodynamics
AXC induced a significant increase in MAP (23%),
and removal of the aortic clamp resulted in a return of
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MAP to baseline values. There were no significant
changes in HR. During AXC, CI significantly
decreased by ÿ13% but returned to the baseline
values after the clamp release. A marked increase in
iSVR (51%) was sustained for the entire AXC period.
All systemic haemodynamic effects occurring during
AXC were transient changes and, after aortic
declamping, parameters presented no significant dif-
ference with preclamp levels (Tables 2 and 3).
Effects of AXC on renal haemodynamics
During AXC, both RBF and renal fraction of CO were
significantly decreased by ÿ35% and ÿ27%, respect-
ively. That was related to a marked increase in RVR
(135%). These alterations induced by AXC worsened
after removal of the aortic clamp (Figs. 2 and 3). The
sustained reduction in RBF (ÿ45%) and in renal frac-
tion of CO (ÿ44%) was indicative of a persistent
increase in RVR (69%), even after aortic declamping
and return of systemic haemodynamics to baseline
(Tables 2 and 3).
Discussion
Systemic changes during aortic cross-clamping have
been studied extensively in many animal models. The
experimental studies performed on dogs are not
homogeneous, because some show an increased CO
during AXC,19,22 whereas others demonstrate a
decreased CO.11,20 Gelman et al.22 found, after AXC
in seven dogs, an insignificant increase in CO and no
changes in MAP. Moursi et al.19 developed a model of
infrarenal AXC at the level of aortic bifurcation in six
dogs and observed a decrease in HR, an increase in
MAP and in CO. Some small animal models, such as
rat, do not allow to study the systemic and renal
changes simultaneously and reliably.9 The studies car-
ried out on pigs demonstrate a haemodynamic behav-
iour which is closer to the human model, as much in
0
500
1000
1500
2000
2500
Pre AXC AXC Post AXC
Time
Pl
as
m
a
 
le
ve
l o
f h
ip
pu
ra
n
Fig. 1. Time course of the plasma radioactivity of 131hippuran in each animal.
Table 1. Variations of plasma radioactivity and extraction fraction of 131I hippuran related to aortic cross-clamping.
PreAXC vs AXC AXC vs PostAXC PreAXC vs PostAXC p value
PHIP ÿ2.6 (ÿ14.5; 5.3) ÿ1.7 (ÿ10.8; 12.2) 1.3 (ÿ9.9; 4.7) 0.905
EHIP 1.3 (ÿ2.6; 3.0) 0 (ÿ1.5; 8) 0 (ÿ2.7; 3.1) 0.741
Rate of extraction fraction of 131I hippuran
PreAXC AXC PostAXC
EHIP 77 (66; 81) 76 (65; 81) 76 (67; 81) 0.828
Values are medians (25; 75%) except p value determined by Friedman test.
AXC: aortic cross-clamping, PHIP: plasma radioactivity of
131I hippuran, EHIP: extraction fraction of
131I hippuran.
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terms of systemic changes as renal ones.8,12,14±18
Seeman-Lodding et al.14 described the effects of AXC
in ten pigs and found an increase in MAP (19%),
SVR (24%) and RBF (11%), but no alterations in SV,
CO or HR. Sundeman et al.15 performed a study in 14
pigs ; AXC increased MAP by 26.5%, SVR by 26.7%
and RVR by 42.7%, but induced no significant changes
in CO, HR or RBF. Five minutes after the aortic clamp
was released, all haemodynamic variables had
returned to preclamp levels, except MAP, SVR and
RVR, which remained increased by 10%, 12%, and
12.5% respectively. Lalak et al.18 reported the effect of
AXC in seven pigs; a significant decrease in RBF was
recorded following release of the aortic clamp, but no
significant changes in CO or MAP. The present study
confirms the similarity of the systemic haemodynamic
changes occurring in pigs compared to humans dur-
ing the clamping and declamping of the aorta. Under
stable conditions of anaesthesia, CO decreased during
AXC while PCWP remained constant.5 In fact from the
physiopathological view point, this reduction of CO
during AXC is not due to a decrease in preload, but is
caused by a mechanism of adjustment to the increase
in afterload following AXC, which produces a
decrease in the iSV since the HR remains stable
(COHR iSV).5
Several experimental and clinical studies have
explored the renal circulation during infrarenal AXC.
Most of the experimental studies which have been
previously conducted have produced controversial
and inconclusive results. RBF has been found
decreased18 or unchanged15,19 while an increase in
Table 2. Systemic and renal haemodynamic variables measured at each period.
PreAXC AXC PostAXC
Systemic variables
ETCO2P (mmHg) 30 (28; 32) 26.5 (22; 29) 28 (23; 31)
SAP (mmHg) 95 (74; 101) 107 (105; 110) 94 (90; 96)
DAP (mmHg) 56 (49; 74) 79 (68; 84) 66 (51; 71)
MAP (mmHg) 77 (62; 96) 96 (87; 103) 81 (67; 85)
HR (bpm) 90 (87; 96) 97 (88; 108) 96 (88; 108)
PCWP (mmHg) 9 (4; 11) 9 (3; 12) 8 (4; 12)
CI (ml/min/kg) 125 (96; 160) 113 (84; 116) 113 (99; 132)
iSVR (IU) 660 (488; 802) 977 (816; 1064) 716 (554; 793)
Renal variables
UO (ml/min) 1.1 (0.5; 1.1) 1.0 (0.5; 2.9) 0.8 (0.5; 1.8)
RBF (ml/min) 204 (129; 455) 169 (96; 278) 138 (84; 218)
RBF/CO (%) 10.6 (7.3; 18.6) 10.9 (4.2;11.8) 6.3 (2.7; 11.9)
RVR (IU) 396 (165; 490) 512 (370; 974) 583 (308; 1311)
Values are medians (25; 75%). AXC: aortic cross-clamping, ETCO2P: end tidal CO2 pressure, SAP: systolic arterial
pressure, DAP: diastolic arterial pressure, MAP: mean arterial pressure, HR: heart rate, bpm: beats per minute,
PCWP: pulmonary capillary wedge pressure, CI: cardiac index, iSVR: indexed systemic vascular resistance, UO:
urinary output, RBF: renal blood flow, RBF/CO: renal fraction of cardiac output, RVR: renal vascular resistance.
Table 3. Variations of systemic and renal haemodynamics related to aortic cross-clamping variations.
PreAXC vs AXC p value PreAXC vs PostAXC p value
Systemic variables
ETCO2P ÿ9.2 (ÿ19.4; 0) NS ÿ6.2 (ÿ9.7; 9.5) NS
SAP 18.2 (9.4; 18.6) 0.005 ÿ3.2 (ÿ7.1; 17.4) NS
DAP 35.2 (13.5; 41.1) 0.005 5.8 (ÿ14.5; 20) NS
MAP 23 (11.6; 38.7) 0.005 0 (ÿ8; 19.6) NS
HR 3.4 (ÿ4.5; 14.2) NS 8.4 (ÿ2.3; 14) NS
PCWP 0 (ÿ10; 12.5) NS 0 (ÿ10; 9.1) NS
CI ÿ13 (ÿ17.7; ÿ5.4) 0.005 ÿ3.6 (ÿ18; 10.1) NS
iSVR 50.9 (24.7; 75.3) 0.005 8.9 (ÿ3.5; 30.1) NS
Renal variables
UO 23 (ÿ7; 91) NS 11 (ÿ35; 144) NS
RBF ÿ35 (ÿ56; ÿ17) 0.016 ÿ45 (ÿ71; ÿ34) 0.005
RBF/CO ÿ27 (ÿ49; ÿ8) 0.036 ÿ44 (ÿ66; ÿ1) 0.016
RVR 135 (30; 179) 0.012 69 (52; 201) 0.007
Values are medians (25; 75%) expressed as percentage (except p value determined by Wilcoxon test). AXC: aortic cross-clamping, ETCO2P:
end-tidal CO2 pressure, NS: non-significant, SAP: systolic arterial pressure, DAP: diastolic arterial pressure, MAP: mean arterial pressure,
HR: heart rate, PCWP: pulmonary capillary wedge pressure, CI: cardiac index, iSVR: indexed systemic vascular resistance, UO: urinary
output, RBF: renal blood flow, RBF/CO: renal fraction of cardiac output, RVR: renal vascular resistance.
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RVR has usually been reported.15,18,19 Many factors
have been suggested to explain the discrepancies
between the experimental studies, mainly anaesthesia
management or species differences, but the method
used to assess the renal perfusion may be accounted
for too. The study of renal haemodynamic conse-
quences of AXC can make use of several well-
established and commonly utilised techniques, such
as the use of electromagnetic or ultrasonic flow
probe,15,19,20 enhanced thermodiffusion electrode,8
laser Doppler flowmetry17 or trapping of labelled
microspheres.22 The technique of clearance of 131
I hippuran offers the advantage of not needing to
place probes, which demand a dissection of the renal
arteries at the origin of arterial spasms and distorted
measurements (electromagnetic or ultrasonic flow
probe). It also offers more accurate results than the
measurement of total blood flow to a specific organ
(laser Doppler flowmetry) which records haemody-
namic events within a small tissue volume and with
great variations according to the different types of
laser Doppler probes; recordings of flux from adjacent
measuring positions often show considerable varia-
tions, even with minimal alterations in probe pos-
ition.23 The radioactive microsphere trapping method
is inadequate in clinical studies because it requires the
removal of tissues and organs. Several limitations
related to the technique can be the source of
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Fig. 2. Individual variations of renal blood flow during the three investigation periods.
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Fig. 3. Individual variations of renal vascular resistance during the three investigation periods.
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significant errors related to the presence of direct
arteriovenous anastomoses, to distention of the capil-
lary lumen by the microspheres, or to the timing of
tissue procurement.22 Besides, this technique does not
permit the continuous monitoring of tissue blood
flow.17 In this study the technique used for adminis-
trating the labelled compound, 131I hippuran, pro-
vided a very stable plasma radioactivity during all
the time of the procedure that is mandatory for
repeated measurements of clearances. Moreover, the
extraction fraction of 131I hippuran was always very
close to the values observed in clinical studies and
may reflect an adequate distribution of intrarenal
blood flow toward both cortical and medullary com-
partments.6 The UO was well maintained by the use of
mannitol allowing the collection of at least 10 ml of
urine for each period and avoiding any washout effect
after each period of measurement. This is of para-
mount importance, because it is the variation of urin-
ary concentration in 131I hippuran which determines
the calculation of RBF. With such rigorous conditions,
the technique of clearance of 131I hippuran thus per-
mits to have an exact and non-aggressive measure-
ment of the renal haemodynamics. It is considered as
the `` gold standard'' in clinical studies6,7 and is easily
reproducible in the animal.9,11,13
The present study demonstrates, as the majority of
studies in humans,1±7 a profound alteration in renal
haemodynamics during infrarenal AXC, characterised
by a 135% increase in RVR and a 35% decrease in RBF.
Renal haemodynamic impairment was associated
with a significant increase in MAP and a significant
decrease in CO. RBF decrease did not correlate with
changes in CO as evidenced by the decreased RBF/
CO ratio. This renal alteration worsened after removal
of the aortic clamp, whereas systemic variables
returned to baseline levels.
In conclusion, an animal model was successfully
established which provides a reliable method to
obtain continuous and simultaneous measurements
of systemic and renal haemodynamic parameters.
This model reproduces similar responses to infrarenal
aortic cross-clamping to those observed in humans. It
appears to be a valuable method for further studies
about pathogenesis of renal vasoconstriction, with
evaluation of new potential vasodilatator agents or
antagonists of humoral factors, and research of para-
crine and autocrine mediators.
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